GHP Biotechnology Awards 2023 communicate much. After taking the formula for three weeks, she became able to talk with her family on a focused subject. Her daughter also noticed that, while she had not previously seemed connected with her surroundings, she became more connected after taking the treatment. She started smiling, asking how her loved ones were and enquiring about her daily plans. Another change was that she stopped speaking about her old address in Tel Aviv and started to focus on her current address in Rishon Le Zion, demonstrating a connection with the present. Her breathing also became better, her mood improved, and she became physically stronger. She was even able to make her own coffee after three years in which was unable to do so. The third subject was another woman in her early 80s who had been diagnosed with Alzheimer’s for four years. She frequently repeated herself and rarely made sense when she spoke. She was also very depressed and said people were watching her. After taking the formula for three weeks her son observed a number of changes, including increased connection with her surroundings, expressing of her feelings, improved mood, sleep problems had stopped, as well as no paranoia and aggression incidences reported. Lastly, the fourth subject was a male who had been diagnosed with mild Alzheimer’s. Before taking the formula, he was very forgetful and was unable to manage his bank account. Afterwards, he showed significant improvement in his focus sleep, and memory. As a result, he stopped forgetting his belongings at shops or home and was able to manage his bank account. His life has returned to their normal routine. No side effects have been reported in any of these case studies. Another illness with devastating consequences for many individuals across the globe is cancer, most commonly breast, lung, prostate, and colon/rectum cancer. According to the World Health Organisation, cancer causes around 10 million deaths per year. In its research, NCM discovered a connection between a treatment which disarms the Covid-19 spike protein and the treatment of cancer cells. Following this discovery, the company was able to create a formula that has been effectively used to treat various forms of cancer. Firstly, NCM’s treatment was used exclusively to help a cancer volunteer patient with basal cell carcinoma and invasive squamous cell carcinoma. After three weeks, it was confirmed that his scans had come back negative, with no metastasis. In another case, the exclusive treatment was used to help a female volunteer in her 50s with breast cancer that had spread to her axillary lymph nodes. Within a few months, the cancer stopped growing and even shrank in size. The patient experienced no side effects and no pain, and she was able to stay in the comfort of her home for the duration of the treatment. From observing her blood tests before and after intervention, NCM also noticed significant improvement in the levels of glucose in her blood, which demonstrates the potential efficacy of the formula in treating diabetes as well as cancer. Lastly, the treatment was used to help a 47-year-old male volunteer diagnosed with colon cancer. The formula improved most of his blood biomarkers, including liver function, alkaline phosphate, and albumin. His tumours decreased in size. In addition, an MRI showed no tumours in his liver during the period he took the formula. The subject reported that during the 21-day period while taking the formula exclusively he felt much better and experienced less tumour pain, could eat again, and could walk five miles a day, which meant the formula was successfully treating the cancer. The subject expressed confidence that the formula helped him, explaining that he knows his body and how it reacts, including when the cancer is active or not. Born in Israel, Rachel R. Alkalay is the incredible mind behind NCM and its life-changing discoveries. Before founding the company, she worked for 20 years as a legal advisor for startups and entrepreneurs in Israel and New York, specialising in the field of patents and intellectual property. She obtained her bachelor’s and master’s degrees in law at a top university in Israel and has a PhD in Law from Queen Mary University in London, where she has also been lecturing. When the Covid-19 pandemic started, Rachel shifted her focus from her research at Queen Mary’s to creating her own company. Having lost her mother and aunt to cancer, as well as a cousin to diabetes complications and a sudden stroke, Rachel was inspired to research treatments for severe and chronic diseases to help individuals and families get through the hardest times of their lives. She established NCM, investing her own resources and fulltime work in the research and development of plantbased lifesaving cures, aiming to make a positive difference in the medical world while protecting the lives of animals. As a result of the innovative treatments it has produced, curing or minimising the symptoms of many diseases, Novel Concepts Medical has won Most Pioneering Life Saving Treatments R&D Company, Middle East, in the Biotechnology Awards 2023. The company continues to carry out ground-breaking research, as well as planning to sell its first products for sugar in the blood reduction, weight reduction and for memory support as food supplements. Contact: Rachel Alkalay Company: Novel Concepts Medical Web Address: https://www. novelconceptsmedical.com/ Credit: Yankale Mazare
RkJQdWJsaXNoZXIy MTUyMDQwMA==